1. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Hiroshi Saeki et al, 2016, Surgery Today CrossRef
  2. Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer
    Yusen Zhu et al, 2017, Pathology & Oncology Research CrossRef
  3. Surgical Resection and Perioperative Chemotherapy
    Hoon Jai Chun et al, 2023, Gastrointestinal Cancer CrossRef
  4. Comparative Outcomes of Laparoscopic Gastrectomy and Open Gastrectomy for Scirrhous Gastric Cancer: A Multicenter Retrospective Cohort Study
    Yusuke Fujita et al, 2021, Annals of Surgery Open CrossRef
  5. Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations
    Jun Peng et al, 2016, The Annals of Thoracic Surgery CrossRef
  6. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma
    Jiaying Deng et al, 2014, Diagnostic Pathology CrossRef
  7. Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
    Akinori Takada et al, 2016, Cancer Medicine CrossRef
  8. Impact of the Pre-operative Chemoradiation Therapy on Complications in Patients with Locally Advanced Esophageal Cancer
    M. S. Shogenov et al, 2019, Malignant tumours CrossRef
  9. Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma
    X-W Cai et al, 2019, Diseases of the Esophagus CrossRef
  10. Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo
    Junfen Ma et al, 2017, Oncology Letters CrossRef
  11. Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment
    Yoshinori Fujiwara et al, 2019, Molecular and Clinical Oncology CrossRef
  12. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma
    Zhongjian Chen et al, 2020, Frontiers in Oncology CrossRef
  13. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis
    Da Zhou et al, 2024, Journal of Evidence-Based Medicine CrossRef